Carregant...

Impact of oral anticoagulant choice for the secondary prevention of venous thromboembolism on the risk of inpatient bleeding

BACKGROUND: Randomized trials suggest that direct oral anticoagulants (DOACs) are at least as effective as warfarin for primary treatment of VTE and that bleeding risk may be lower for some DOACs relative to warfarin. However, there is very little information regarding potential bleeding risks for D...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Res Pract Thromb Haemost
Autors principals: MacLehose, Richard F., Zakai, Neil A., Walker, Rob F., Alonso, Alvaro, Adams, Terrence, Lutsey, Pamela L.
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2021
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8105158/
https://ncbi.nlm.nih.gov/pubmed/33977213
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/rth2.12514
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!